Author Archives: Toby Seddon

About Toby Seddon

Professor and Head of School of Law at the University of Manchester. Interested in new ideas and thinking about drug policy.

Drinking guidelines

Listening to the Today programme this morning, I was interested to hear the Chief Medical Officer, Dame Sally Davies, defending the new guidelines on weekly limits for safe drinking. She was particularly keen to stress their basis in science and evidence. … Continue reading

Posted in Uncategorized | Leave a comment

Free downloads

As part of the general sprucing up of this website, I have added a page for ‘Papers’ which includes free-to-access articles and reports. I’ll continue to add to this. In the meantime, feel free to share and if there are … Continue reading

Posted in Uncategorized | Leave a comment

Revamped blog & website

To start the new year, I’ve revamped this blog and website, to include new pages covering my books, papers and projects. Work is ongoing to build up the content but do take a look round.

Posted in Uncategorized | Leave a comment

Laying down the lasso

A recent report in The Guardian, on a ‘huge rise’ in illicit online sales of pharmaceuticals, reminded me of one of the best books I read in 2014: legal scholar Anupam Chander’s The Electronic Silk Road. Chander’s great insight, to … Continue reading

Posted in Uncategorized | Leave a comment

Regulation and global drug policy

On December 4th, I will be giving a public lecture in Manchester. The lecture’s premise is that we have reached a dead-end in our thinking about global illicit drug problems. The argument I will make is that the way out … Continue reading

Posted in Uncategorized | Leave a comment

HASC, Clegg and drug policy reform

The publication of the Home Affairs Select Committee report on drug policy, followed by Nick Clegg’s intervention on the matter, raised a huge amount of interest in the field, prompting a flurry of media appearances, tweets, blogs and the like. … Continue reading

Posted in Uncategorized | Leave a comment

More politics, less evidence!

A familiar trope in drug policy debates is the idea that policy-makers should pay closer attention to research and that there is a choice to be made between, on one side, ‘science’ and ‘evidence’, and on the other, ‘dogma’ and … Continue reading

Posted in Uncategorized | 3 Comments